封面
市场调查报告书
商品编码
1775449

全球手术器材市场:2025-2030 年预测

Global Surgical Instruments Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计手术器械市场规模将从 2025 年的 228.37 亿美元成长到 2030 年的 331.54 亿美元,复合年增长率为 7.74%。

心血管疾病盛行率高

冠心病和风湿性心臟疾病等心血管心臟疾病是外科器械需求的主要驱动力。这些疾病需要先进的外科手术干预,例如血管成形术、心臟瓣膜置换术和冠状动脉绕道手术术,而这些手术高度依赖专用器械。随着医疗保健系统优先考虑有效的治疗方法以改善患者的预后和生活质量,这些疾病的全球负担正在推动市场成长。

世界人口老化

老年人口的快速成长对市场扩张做出了巨大贡献。与老龄化相关的疾病,尤其是心血管疾病,通常需要手术干预,这增加了对手术器械的需求。这种人口趋势给医疗保健系统带来了采用先进手术技术的压力,进一步推动了预测期内的市场成长。

微创手术的兴起

微创手术 (MIS) 的采用是主要的成长动力,包括机器人手术和非机器人手术。经皮冠状动脉介入治疗 (PCI)、球囊血管成形术和雷射血管成形术等 MIS 手术利用导管、球囊导管和支架等专用器械来治疗动脉阻塞等疾病。与传统的开放性手术相比,这些手术可实现更快的恢復、更短的住院时间、最小的疤痕和更少的术后併发症。例如,微创冠状动脉绕道手术术和用于治疗心律不整的射频消融术采用小切口和基于导管的方法,使患者能够快速恢復日常活动。对 MIS 的日益增长的偏好正在推动手术器械的销售,创造永续的市场机会。

紧急情况增加

全球道路交通事故数量的不断增加,导致紧急外科手术数量激增,进一步推动了对手术器械的需求。创伤病例通常需要即时进行手术干预,这增加了对先进器械的需求,以有效治疗严重损伤。

外科手术的进展

外科手术技术的进步正在改变市场,使其能够更快、更有效率地完成手术,并改善治疗效果。动脉粥状硬化斑块切除术状硬化斑块切除术(使用配备刮除器的旋转导管去除动脉斑块)和心肌血运重组(TMR)等手术都依赖尖端仪器。同样,心臟瓣膜置换术和起搏器植入术也变得更加精准,从而减少了併发症并提高了患者的生活品质。这些进步推动了对专用手术器械的需求,从而支持了市场的成长。

区域洞察

北美占据主要市场占有率,这得益于美国高昂的医疗支出和其先进的医疗设施。该地区强大的医疗基础设施支持先进外科技术的采用。另一方面,亚太地区是成长最快的市场之一,因为该地区需要外科手术介入的慢性疾病发生率很高。该地区各国正在投资改善医疗保健,进一步推动了对手术器材的需求。

市场挑战

器械相关感染是市场成长的显着限制因素。导管相关感染疾病虽然罕见,但可能严重且难以治疗,尤其对于接受血管成形术和心导管插入术等手术的患者。免疫力较弱的患者和需要多次手术的患者发生手术部位感染等併发症的风险更高。此类担忧需要采取严格的感染控制措施,这可能导致成本增加和器械核准延迟,对市场成长产生一定影响。

结论

预计到2028年,手术器械市场将迎来强劲成长,这得益于心血管疾病盛行率的上升、人口老化以及微创和先进外科手术的日益普及。北美和亚太地区是主要的成长地区,这得益于强劲的医疗保健投资和疾病的流行。然而,与器械相关感染相关的挑战需要谨慎管理才能维持市场动能。产业参与者必须专注于技术创新和感染控制,才能抓住日益增长的手术器械需求。

本报告的主要优点

  • 深刻分析:获得涵盖主要和新兴地区的深入市场洞察,重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
  • 竞争格局:了解全球主要企业所采用的策略策略,并了解正确策略带来的潜在市场渗透。
  • 市场趋势和驱动因素:探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议:利用洞察力进行策略决策,在动态环境中开闢新的业务流和收益。
  • 受众范围广泛:对于新兴企业、研究机构、顾问公司、中小企业和大型企业都有益且具有成本效益。

它有什么用途?

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、监管影响、新产品开发、竞争情报

研究范围

  • 2022 年至 2024 年的历史数据和 2025 年至 2030 年的预测数据
  • 成长机会、挑战、供应链前景、法律规范与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 收益成长和预测包括国家在内的细分市场和地区分析
  • 公司概况(特别是财务状况和关键发展)

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 研究范围
  • 市场区隔

第三章 商业景气

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

第五章。按手术类型分類的手术器械市场

  • 介绍
  • 开放性手术
  • 微创手术
  • 机器人手术
  • 非机器人(内视镜)手术

第六章 手术器械市场:依产品

  • 介绍
  • 手术缝合线和缝合钉
  • 手持式手术器械
  • 电外科设备
  • 其他手术设备

第七章 手术器械市场:依手术程序

  • 介绍
  • 白内障手术
  • 心血管手术
  • 剖腹产
  • 背痛手术
  • 其他的

第八章 手术器械市场(依最终用户)

  • 介绍
  • 医院
  • 门诊手术中心
  • 专科诊所
  • 生命科学与生物医学研究组织

第九章 手术器械市场(按地区)

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 其他的

第十章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争仪錶板

第十一章 公司简介

  • Medtronic plc
  • Johnson & Johnson
  • Stryker Corporation
  • Intuitive Surgical, Inc.
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Zimmer Biomet Holdings, Inc.
  • Becton, Dickinson and Company
  • CONMED Corporation
  • Olympus Corporation

第十二章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061613459

The Global Surgical Instruments Market is expected to grow from USD 22.837 billion in 2025 to USD 33.154 billion in 2030, at a CAGR of 7.74%.

High Prevalence of Cardiovascular Diseases

Cardiovascular diseases, including coronary heart disease and rheumatic heart disease, are a primary driver of demand for surgical instruments. These conditions necessitate advanced surgical interventions, such as angioplasty, heart valve replacement, and coronary artery bypass grafts, which rely heavily on specialized instruments. The global burden of these diseases fuels market growth, as healthcare systems prioritize effective treatments to improve patient outcomes and quality of life.

Aging Global Population

The rapidly growing geriatric population significantly contributes to market expansion. Age-related diseases, particularly cardiovascular conditions, often require surgical interventions, increasing the demand for surgical instruments. This demographic trend places pressure on healthcare systems to adopt advanced surgical technologies, further driving market growth over the forecast period.

Rise in Minimally Invasive Surgeries

The adoption of minimally invasive surgeries (MIS) is a major growth driver, encompassing both robotic and non-robotic procedures. MIS techniques, such as percutaneous coronary intervention (PCI), balloon angioplasty, and laser angioplasty, utilize specialized instruments like catheters, balloon catheters, and stents to treat conditions like arterial blockages. These procedures offer faster recovery times, reduced hospital stays, minimal scarring, and lower post-surgical complications compared to traditional open surgeries. For instance, minimally invasive coronary artery bypass grafts and radiofrequency ablation for arrhythmias use small incisions or catheter-based approaches, enabling patients to resume daily activities quickly. The growing preference for MIS is boosting sales of surgical instruments, creating sustainable market opportunities.

Increase in Emergency Cases

The rising number of road accidents globally has led to a surge in emergency surgical procedures, further propelling demand for surgical instruments. Trauma cases often require immediate surgical intervention, driving the need for advanced tools to address critical injuries effectively.

Advancements in Surgical Procedures

Technological advancements in surgical techniques are transforming the market by enabling faster, more efficient procedures with improved outcomes. Procedures like atherectomy, which uses a catheter with a rotating shaver to remove arterial plaques, and transmyocardial revascularization (TMR), which employs laser beams to treat severe angina, rely on cutting-edge instruments. Similarly, heart valve replacement surgeries and pacemaker implantations have become more precise, reducing complications and enhancing patient quality of life. These advancements drive demand for specialized surgical instruments, supporting market growth.

Regional Insights

North America holds a significant market share, driven by high healthcare expenditure in the United States and access to state-of-the-art facilities. The region's robust healthcare infrastructure supports the adoption of advanced surgical technologies. Meanwhile, the Asia-Pacific region is among the fastest-growing markets due to the high prevalence of chronic diseases requiring surgical intervention. Countries in this region are investing in healthcare improvements, further fueling demand for surgical instruments.

Market Challenges

Device-associated infections pose a notable restraint on market growth. Catheter-related infections, though rare, can be severe and difficult to treat, particularly in patients undergoing procedures like angioplasty or cardiac catheterization. Patients with weakened immune systems or those requiring multiple surgeries are at higher risk of complications, such as surgical-site infections. These concerns necessitate stringent infection control measures, which can increase costs and delay device approvals, moderately impacting market growth.

Conclusion

The surgical instruments market is set for robust growth through 2028, driven by the rising prevalence of cardiovascular diseases, an aging population, and the increasing adoption of minimally invasive and advanced surgical procedures. North America and Asia-Pacific are key growth regions, supported by strong healthcare investments and disease prevalence. However, challenges related to device-associated infections require careful management to sustain market momentum. Industry players must focus on innovation and infection control to capitalize on the growing demand for surgical instruments.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Surgery Type

  • Open Surgery
  • Minimally Invasive Surgery
  • Robotic Surgery
  • Non-Robotic (Endoscopic) Surgery

By Product

  • Surgical sutures and staples
  • Hand-held surgical devices
  • Electrosurgical devices
  • Other Surgical Devices

By Surgical Procedure

  • Cataract Surgery
  • Heart Surgery
  • Caesarean Section
  • Low Back Pain Surgery
  • Others

By End User

  • Hospital
  • Ambulatory Surgical Center
  • Specialized Clinic
  • Life Sciences and Biomedical Research Organization

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Others
  • Middle East and Africa
  • UAE
  • Israel
  • Saudi Arabia
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. SURGICAL INSTRUMENTS MARKET BY SURGERY TYPE

  • 5.1. Introduction
  • 5.2. Open Surgery
  • 5.3. Minimally Invasive Surgery
  • 5.4. Robotic Surgery
  • 5.5. Non-Robotic (Endoscopic) Surgery

6. SURGICAL INSTRUMENTS MARKET BY PRODUCT

  • 6.1. Introduction
  • 6.2. Surgical sutures and staples
  • 6.3. Hand-held surgical devices
  • 6.4. Electrosurgical devices
  • 6.5. Other Surgical Devices

7. SURGICAL INSTRUMENTS MARKET BY SURGICAL PROCEDURE

  • 7.1. Introduction
  • 7.2. Cataract Surgery
  • 7.3. Heart Surgery
  • 7.4. Caesarean Section
  • 7.5. Low Back Pain Surgery
  • 7.6. Others

8. SURGICAL INSTRUMENTS MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Ambulatory Surgical Center
  • 8.4. Specialized Clinic
  • 8.5. Life Sciences and Biomedical Research Organization

9. SURGICAL INSTRUMENTS MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Spain
    • 9.4.5. Italy
    • 9.4.6. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. Australia
    • 9.6.5. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Medtronic plc
  • 11.2. Johnson & Johnson
  • 11.3. Stryker Corporation
  • 11.4. Intuitive Surgical, Inc.
  • 11.5. Boston Scientific Corporation
  • 11.6. B. Braun Melsungen AG
  • 11.7. Zimmer Biomet Holdings, Inc.
  • 11.8. Becton, Dickinson and Company
  • 11.9. CONMED Corporation
  • 11.10. Olympus Corporation

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key benefits for the stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations